Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Haimen Universal Pharmaceutical is a Chinese pharmaceutical company specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. Based in Haimen, Jiangsu Province, the company focuses on a variety of therapeutic areas including anti-infectives, cardiovascular health, and anti-inflammatory treatments. They operate as a contract manufacturing organization (CMO) and a supplier of bulk drug substances to both domestic and international markets. The company maintains manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards to ensure the quality of its chemical synthesis and pharmaceutical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Haimen Universal Pharmaceutical.